754 related articles for article (PubMed ID: 25298370)
1. Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines.
Barrett R; Ornelas L; Yeager N; Mandefro B; Sahabian A; Lenaeus L; Targan SR; Svendsen CN; Sareen D
Stem Cells Transl Med; 2014 Dec; 3(12):1429-34. PubMed ID: 25298370
[TBL] [Abstract][Full Text] [Related]
2. Modeling neurological diseases with induced pluripotent cells reprogrammed from immortalized lymphoblastoid cell lines.
Fujimori K; Tezuka T; Ishiura H; Mitsui J; Doi K; Yoshimura J; Tada H; Matsumoto T; Isoda M; Hashimoto R; Hattori N; Takahashi T; Morishita S; Tsuji S; Akamatsu W; Okano H
Mol Brain; 2016 Oct; 9(1):88. PubMed ID: 27716287
[TBL] [Abstract][Full Text] [Related]
3. Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent stem cells.
Rajesh D; Dickerson SJ; Yu J; Brown ME; Thomson JA; Seay NJ
Blood; 2011 Aug; 118(7):1797-800. PubMed ID: 21708888
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming LCLs to iPSCs Results in Recovery of Donor-Specific Gene Expression Signature.
Thomas SM; Kagan C; Pavlovic BJ; Burnett J; Patterson K; Pritchard JK; Gilad Y
PLoS Genet; 2015 May; 11(5):e1005216. PubMed ID: 25950834
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells.
Choi SM; Liu H; Chaudhari P; Kim Y; Cheng L; Feng J; Sharkis S; Ye Z; Jang YY
Blood; 2011 Aug; 118(7):1801-5. PubMed ID: 21628406
[TBL] [Abstract][Full Text] [Related]
6. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
Drozd AM; Walczak MP; Piaskowski S; Stoczynska-Fidelus E; Rieske P; Grzela DP
Stem Cell Res Ther; 2015 Jun; 6(1):122. PubMed ID: 26088261
[TBL] [Abstract][Full Text] [Related]
7. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
8. Highly efficient induced pluripotent stem cell reprogramming of cryopreserved lymphoblastoid cell lines.
Kumar S; Curran JE; Espinosa EC; Glahn DC; Blangero J
J Biol Methods; 2020; 7(1):e124. PubMed ID: 31976351
[TBL] [Abstract][Full Text] [Related]
9. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
10. Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions.
Swistowski A; Peng J; Liu Q; Mali P; Rao MS; Cheng L; Zeng X
Stem Cells; 2010 Oct; 28(10):1893-904. PubMed ID: 20715183
[TBL] [Abstract][Full Text] [Related]
11. Do Induced Pluripotent Stem Cell Characteristics Correlate with Efficient In Vitro Smooth Muscle Cell Differentiation? A Comparison of Three Patient-Derived Induced Pluripotent Stem Cell Lines.
Zhou Y; Kang G; Wen Y; Briggs M; Sebastiano V; Pederson R; Chen B
Stem Cells Dev; 2018 Oct; 27(20):1438-1448. PubMed ID: 30153084
[TBL] [Abstract][Full Text] [Related]
12. Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery.
Jang J; Yoo JE; Lee JA; Lee DR; Kim JY; Huh YJ; Kim DS; Park CY; Hwang DY; Kim HS; Kang HC; Kim DW
Exp Mol Med; 2012 Mar; 44(3):202-13. PubMed ID: 22179105
[TBL] [Abstract][Full Text] [Related]
13. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
14. Utility of Lymphoblastoid Cell Lines for Induced Pluripotent Stem Cell Generation.
Kumar S; Curran JE; Glahn DC; Blangero J
Stem Cells Int; 2016; 2016():2349261. PubMed ID: 27375745
[TBL] [Abstract][Full Text] [Related]
15. Standards for Deriving Nonhuman Primate-Induced Pluripotent Stem Cells, Neural Stem Cells and Dopaminergic Lineage.
Yang G; Hong H; Torres A; Malloy KE; Choudhury GR; Kim J; Daadi MM
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227600
[TBL] [Abstract][Full Text] [Related]
16. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11.
Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
Stem Cell Res; 2016 May; 16(3):553-6. PubMed ID: 27346190
[TBL] [Abstract][Full Text] [Related]
17. microRNA and mRNA interactions in induced pluripotent stem cell reprogramming of lymphoblastoid cell lines.
Kumar S; Espinosa EC; Leandro AC; Curran JE; Blangero J
Am J Stem Cells; 2019; 8(2):28-37. PubMed ID: 31523484
[TBL] [Abstract][Full Text] [Related]
18. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells.
Febbraro F; Chen M; Denham M
Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617
[TBL] [Abstract][Full Text] [Related]
19. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.B11.
Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
Stem Cell Res; 2016 May; 16(3):589-92. PubMed ID: 27346191
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of lymphoblastoid-derived iPSCs into functional cardiomyocytes, neurons and myoblasts.
Poulin H; Martineau L; Racine V; Puymirat J; Chahine M
Biochem Biophys Res Commun; 2019 Aug; 516(1):222-228. PubMed ID: 31208718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]